TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Investing
Canopy Growth Corp. releases Q3 Earnings: Don’t Be Fooled
Investing
Canopy Growth Corp.’s TSX Marijuana Niche Has Just Been Invaded
Dividend Stocks
Want to Collect Dividends From Legalized Marijuana? Here’s How
Investing
Better Buy: Aphria Inc. or Canopy Growth Corp.?
Investing
Is Canopy Growth Corp. a Good Investment?
Investing
Should Investors Consider Canopy Growth Corp.?
Investing
Canopy Growth Corp.: Can Investors Rely on Ottawa to Deliver?
Tech Stocks
Why 2016 Was the “1999” for Marijuana Stocks: When News Trumps Fundamentals
Investing
My Top Marijuana Growth Stock for 2017
Investing
Canopy Growth Corp. May Be Severely Undervalued
Investing
Canopy Growth Corp. Joins an Elite Crowd